Skip to content

Clinical trials

Phase 2 Leukemia, Megakaryoblastic, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Megakaryoblastic, Acute Phase: Phase 2 Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20013
20021
20031
20046
20051
20066
20073
20089
20092
20104
20114
20121
20132
20144
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Terminated12
Unknown status3
Withdrawn3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)16
Fred Hutchinson Cancer Center7
Case Comprehensive Cancer Center6
SWOG Cancer Research Network4
Alliance for Clinical Trials in Oncology3
Roswell Park Cancer Institute3
City of Hope Medical Center2
Eastern Cooperative Oncology Group2
European Organisation for Research and Treatment of Cancer - EORTC2
Memorial Sloan Kettering Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Megakaryoblastic, Acute67
Leukemia, Erythroblastic, Acute66
Leukemia, Myeloid, Acute65
Leukemia, Monocytic, Acute61
Leukemia, Myelomonocytic, Acute59
Congenital Abnormalities46
Leukemia33
Leukemia, Basophilic, Acute16
Leukemia, Eosinophilic, Acute16
Anemia, Refractory, with Excess of Blasts10

Trials

Showing 51 to 67 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.